BLUE - bluebird bio, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts21212322
Avg. Estimate-2.63-3.34-12.75-12.12
Low Estimate-3.95-4.36-15.9-15.8
High Estimate-0.190.81-7.35-5.75
Year Ago EPS-3.55-3.73-14.31-12.75
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts19192321
Avg. Estimate66.7M25.47M152.51M158.91M
Low Estimate7.44M1.88M40M60M
High Estimate208.5M205.32M443M256.04M
Year Ago Sales13.3M8.91M44.67M152.51M
Sales Growth (year/est)401.70%185.90%241.40%4.20%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-3.06-3.52-3.79-4.01
EPS Actual-3.55-3.73-4.04-3.64
Difference-0.49-0.21-0.250.37
Surprise %-16.00%-6.00%-6.60%9.20%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-2.63-3.34-12.75-12.12
7 Days Ago-2.63-3.34-12.75-12.12
30 Days Ago-2.63-3.34-12.75-12.12
60 Days Ago-4.06-4.01-15.93-13.44
90 Days Ago-4.1-4.04-16.06-13.55
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesBLUEIndustrySector(s)S&P 500
Current Qtr.25.90%N/AN/AN/A
Next Qtr.10.50%N/AN/AN/A
Current Year10.90%N/AN/AN/A
Next Year4.90%N/AN/AN/A
Next 5 Years (per annum)-66.50%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A